News | Dicerna™ Pharmaceuticals

Dicerna Pharmaceuticals

Our Company
Our Technology
Pipeline
- About Primary Hyperoxaluria
  - About DCR-PHXC
- Compassionate Use Policy
Patients
Investors & Media

Our Company
Our Technology
Pipeline
- About Primary Hyperoxaluria
  - About DCR-PHXC
- Compassionate Use Policy
Patients
Investors & Media

Search for:

News
Careers
Contact

Home /

News

Dicerna Pharmaceuticals

Our Mission

Dicerna^TM Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, viral infectious diseases, chronic liver diseases, and cardiovascular diseases.

Our Company
Our Technology
Pipeline
Patients
Investors & Media

News
Careers
Contact

Privacy Policy
Cookies Policy
Copyright Info
Terms of Use
Site Map